EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Differences in the action of the ergot derivatives bromocriptine lisuride and lsd on the acetylcholine turnover in striatum and the mesolimbic structures of rat brain


Biogenic Amines 2(4): 305-316
Differences in the action of the ergot derivatives bromocriptine lisuride and lsd on the acetylcholine turnover in striatum and the mesolimbic structures of rat brain
The effects of the ergot derivatives bromocriptine, lisuride and LSD on the acetylcholine turnover in striatum and mesolimbic structures of rat brain were estimated by using the finite differences method. The acetylcholine and choline contents were measured radioenzymatically. After intravenous pulse injection of [3H] choline the radioactivity of both [3H] acetylcholine and [3H] choline was measured in the above brain areas. After bromocriptine administration (30 mg/kg i.p.) the acetylcholine turnover was decreased in striatum, nucleus accumbens and olfactory tubercle, respectively. Both pretreatment with lisuride (0.4 mg/kg i.p.) and LSD (0.1 mg/kg i.p.) led to an increase in the acetylcholine turnover in the mesolimbic nuclei, whereas the striatum was unaffected by these drugs. The effects of bromocriptine on the rate of cholinergic activity provides further evidence for an inhibitory dopaminergic modulation of cholinergic interneurons in the striatum and in the mesolimbic nuclei. The effects of lisuride and LSD on cholinergic neurons in the mesolimbic areas appear to be mediated through a preferential action on dopaminergic and serotoninergic autoregulatory processes in the ventral tegmental area and in the raphe nuclei, respectively, leading to an disinhibition of cholinergic neurons. The lack of modification of the acetylcholine turnover in the striatum after both drugs refers to several pharmacological and functional differences between the nigrostriatal and mesolimbic dopamine systems. The differential response of striatal and mesolimbic dopamine systems to various drugs appears to be due to differences in the modulation of dopamine synthesis and firing rate of dopamine neurons consequent to differences in autoregulatory processes and negative feed back mechanisms.


Accession: 005151064



Related references

Differences in the dopaminergic effects of the ergot derivatives bromocriptine, lisuride and d-LSD as compared with apomorphine. European Journal of Pharmacology 51(2): 157-166, 1978

Various dose-dependent influences of apomorphine on the acetylcholine turnover in striatum and mesolimbic areas of rat brain. Biomedica Biochimica Acta 42(7-8): 937-946, 1983

Effect of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brain. European Journal of Pharmacology 41(3): 261-273, 1977

Hypothermic action of lisuride in rats and differences to bromocriptine in the antagonistic effect of neuroleptics. Naunyn-Schmiedeberg's Archives of Pharmacology 306(2): 147-151, 1979

Effect of lisuride and other ergot derivatives on mono aminergic neuro transmission in rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology 297(SUPPL II): R54, 1977

Dual action on central dopamine function of trans di hydro lisuride a 9 10 di hydrogenated analog of the ergot dopamine agonist lisuride. Life Sciences 32(4): 421-432, 1983

Action of apomorphine, bromocriptine and lergotrile on gamma-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum. Journal of Neural Transmission 58(3-4): 153-168, 1983

Anorectic effect of lisuride and other ergot derivatives in the rat. European Journal of Pharmacology 64(2-3): 133-141, 1980

DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease. Movement Disorders 17 Suppl 4: S74-S78, 2002

Radioreceptor assay for ergot derivatives, transdihydrolisuride and lisuride, in biological fluids. Journal of Pharmacological Methods 11(4): 263-270, 1984